Patents Assigned to HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARMACEUTICAL FACTORY
  • Salts and crystal forms of diaza-benzofluoranthrene compounds
    Patent number: 11124506
    Abstract: The present invention discloses to a hydrochloride salt, a citrate salt, a phosphate salt or a sulfate salt of compound 1, the crystal forms of the aforementioned salts, and a preparation method thereof. The present invention also relates their use in the preparation of a medicament for the treatment of cerebral apoplexy or epilepsy.
    Type: Grant
    Filed: August 3, 2017
    Date of Patent: September 21, 2021
    Assignee: HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARMACEUTICAL FACTORY
    Inventors: Qingqing Lu, Shenyi Shi, Tiezhong Bai, Shujie Yuan, Zhengwu Li, Qiaofen Hu, Yijie Cao, Jing Gao, Hui Ding, Jinhua Li, Guanghai Xu, Zheng Wang, Xin Jin
  • Diaza-benzofluoranthrene compounds
    Patent number: 10017507
    Abstract: Disclosed are a series of diaza-benzofluoranthrene compounds. The present invention particularly relates to a compound represented by formula (I), pharmaceutically acceptable salts or tautomers thereof.
    Type: Grant
    Filed: February 2, 2016
    Date of Patent: July 10, 2018
    Assignee: HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARMACEUTICAL FACTORY
    Inventors: Shujie Yuan, Xinchun Yang, Jinlong Zhao, Daoxu Zhang, Mingda Sun, Jiaji Liu, Tao Wei, Huanan Zhao, Yunfu Luo, Chundao Yang